There is perhaps no more exciting trend in technology today than the growing use of artificial intelligence (AI) in healthcare.
And what is especially exciting is the fact that my favorite stock in this sector has been beaten down by Wall Street from a high of over $35 a share to around $15 a share currently.
Renalytix AI PLC (RNLX) hails from the U.K., and its machine learning algorithm identifies patients that are at risk of developing chronic kidney diseases. Let’s take a dive into exactly what is unique about the Renalytix’s technology–and why the company is sitting in the proverbial catbird seat, thanks to demographics.
The post Now Is the Time to Buy This AI Healthcare Company originally appeared at Investors Alley.